[go: up one dir, main page]

CN1179975A - A kind of pharmaceutical composition for treating osteoporosis - Google Patents

A kind of pharmaceutical composition for treating osteoporosis Download PDF

Info

Publication number
CN1179975A
CN1179975A CN 97116975 CN97116975A CN1179975A CN 1179975 A CN1179975 A CN 1179975A CN 97116975 CN97116975 CN 97116975 CN 97116975 A CN97116975 A CN 97116975A CN 1179975 A CN1179975 A CN 1179975A
Authority
CN
China
Prior art keywords
parts
servings
pharmaceutical composition
grams
rhubarb
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN 97116975
Other languages
Chinese (zh)
Other versions
CN1059115C (en
Inventor
苏顺兴
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97116975A priority Critical patent/CN1059115C/en
Publication of CN1179975A publication Critical patent/CN1179975A/en
Application granted granted Critical
Publication of CN1059115C publication Critical patent/CN1059115C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a pharmaceutical composition for treating osteoporosis, which comprises ginseng, sheep bone, live eel, prepared rhizome of rehmannia, Szechuan lovage rhizome, Chinese angelica, red paeony root, red-rooted salvia root, elderberry, native copper, crab, oyster shell, rhubarb, roasted monkshood, roasted nux vomica, peach kernel and safflower.

Description

一种治疗骨质疏松症的药物组合物A kind of pharmaceutical composition for treating osteoporosis

本发明是一种治疗骨质疏松症的药物组合物,该组合物的组成为我国的传统中草药,对骨质疏松症的治疗和预防具有良好的功效,本发明还提供了以该组合物制备而成的药剂,属于中药领域,The invention is a pharmaceutical composition for treating osteoporosis. The composition is traditional Chinese herbal medicine in my country, which has good efficacy in the treatment and prevention of osteoporosis. The invention also provides The medicament formed belongs to the field of traditional Chinese medicine,

随着现代生活水平的提高,人口寿命逐渐增长,老年人口越来越多,由此带来的退行性生理疾病-原发性骨质疏松症已经成为老年健康的重要疾病之一。骨质疏松症是一种老年病,常见病,目前国内尚无特效的中药制剂。骨质疏松症的特征是骨量低下,骨组织微结构退化导致骨脆性增加,极易造成腰椎压缩性骨折、股骨颈骨折及手腕部、桡骨骨折。这些骨折,尤其是腰椎骨折,往往在没有明显外力作用下发生,常常表现突然腰背剧痛始被发现。随着人口寿命的增长,老年人数的增多,这种病的危害就越来越严重。因此,寻找一种有效预防和治疗骨质疏松症的中药,是当前医学界的重要课题之一。With the improvement of modern living standards, the life expectancy of the population is gradually increasing, and the elderly population is increasing. The resulting degenerative physiological disease-primary osteoporosis has become one of the important diseases of the health of the elderly. Osteoporosis is a kind of senile disease, a common disease, and there is no specific Chinese medicine preparation in China at present. Osteoporosis is characterized by low bone mass and microarchitectural degradation of bone tissue leading to increased bone fragility, which can easily cause lumbar vertebral compression fractures, femoral neck fractures, wrist and radius fractures. These fractures, especially lumbar fractures, often occur without obvious external force, and often manifest as sudden severe back pain. Along with the growth of population life expectancy, the increase of old people's number, the harm of this disease is just more and more serious. Therefore, finding a kind of Chinese medicine for effectively preventing and treating osteoporosis is one of the important topics in the current medical circle.

本发明目的是开发一种治疗骨质疏松症的药物组合物。The purpose of the present invention is to develop a pharmaceutical composition for treating osteoporosis.

根据中医“肾主骨”的理论,骨质疏松症患者肾虚是病之根本。治病必求于本,且肾虚又有肾阴虚、肾阴虚之分。运用中医辩证施治的原则,按照全国关于肾阴虚、肾阳虚诊断标准,对本病肾阳虚者,补肾阳,填精养血,壮骨舒筋,活血祛瘀止痛。发明人在临床实践中通过大量病例总结,研制出了治疗骨质疏松症偏肾阳虚的药物。According to the theory of "kidney governs bones" in traditional Chinese medicine, kidney deficiency is the root of the disease in patients with osteoporosis. Curing must seek at the root, and kidney deficiency can be divided into kidney-yin deficiency and kidney-yin deficiency. Using the principle of TCM dialectical treatment, in accordance with the national diagnostic criteria for kidney yin deficiency and kidney yang deficiency, for those with kidney yang deficiency in this disease, tonify kidney yang, replenish essence and nourish blood, strengthen bones and relax tendons, promote blood circulation, remove blood stasis and relieve pain. The inventor has developed a medicine for treating osteoporosis partial kidney yang deficiency through a large number of case studies in clinical practice.

本发明药物组合物按重量份计其组成是:The composition of the pharmaceutical composition of the present invention is in parts by weight:

人参     20-80份Ginseng 20-80 parts

羊骨     20-80份Lamb bone 20-80 parts

熟地     20-80份Rehmannia 20-80 parts

活鳝鱼   80-120份Live eel 80-120 servings

当归     30-80份Angelica 30-80 servings

赤芍     30-80份Paeoniae Rubra 30-80 parts

丹参     30-80份Danshen 30-80 parts

接骨木   80-120份Elderberry 80-120 servings

自然铜   80-120份Natural copper 80-120 parts

蟹       80-120份Crab 80-120 servings

大黄     30-80份Rhubarb 30-80 parts

炙马钱子 30-80份Roasted horse money 30-80 parts

桃仁     10-40份10-40 parts of peach kernel

红花     10-40份Safflower 10-40 parts

川芎     30-80份Chuanxiong 30-80 parts

炙川乌   30-80份Zhichuan black 30-80 servings

牡蛎     80-120份Oysters 80-120 servings

本发明所述的药物组合物其优选重量配比为:Its preferred weight ratio of the pharmaceutical composition of the present invention is:

人参      50份Ginseng 50 servings

羊骨      50份Lamb bones 50 parts

熟        50份Cooked 50 servings

活鳝鱼    100份Live eel 100 servings

当归      50份Angelica 50 servings

赤芍      50份Radix Paeoniae Alba 50 parts

丹参      50份Danshen 50 parts

接骨木    100份elderberry 100 servings

自然铜    100份Natural copper 100 parts

蟹        100份Crab 100 servings

大黄      50份rhubarb 50 parts

炙马钱子  50份Roasted horse money 50 parts

桃仁      15份15 servings of peach kernels

红花      15份15 servings of safflower

川芎      50份Chuanxiong 50 parts

炙川乌    50份Zhichuan black 50 servings

牡蛎      100份Oysters 100 servings

本发明所述的药物组合物,可以按照常规的制剂工艺,制备成任何一种适合于临床上使用的药物剂型。如,丸剂、片剂、胶囊剂、散记、糖浆剂、口服液、混悬剂、颗粒剂等。The pharmaceutical composition of the present invention can be prepared into any pharmaceutical dosage form suitable for clinical use according to conventional preparation techniques. For example, pills, tablets, capsules, powders, syrups, oral liquids, suspensions, granules, etc.

在制备成本发明上述的药物剂型过程中,可以加入常规的药物赋性剂,例如,崩解剂、粘合剂、调味剂、防腐剂、填充剂、增溶剂、助溶剂、润滑剂、色素等。During the preparation of the above-mentioned pharmaceutical dosage forms of the present invention, conventional pharmaceutical excipients, such as disintegrants, binders, flavoring agents, preservatives, fillers, solubilizers, solubilizers, lubricants, pigments, etc., can be added.

本发明药物丸剂(商品名为勇骨丹)的制备方法是:The preparation method of medicine pill of the present invention (trade name is brave bone pill) is:

将人参、羊骨、活鳝鱼、蟹速冻干燥,研为粉末。自然铜、牡蛎、大黄、炙川乌、炙马钱子研细末,余下诸药按药典制剂通则规定制成清膏,然后与上述药粉混合,炼蜜为丸,每丸重6克。Ginseng, mutton bone, live eel and crab are quick-freeze-dried and ground into powder. Natural copper, oyster, rhubarb, Zhichuanwu, and Zhinxuezi were ground into fine powder, and the rest of the medicines were made into a clear ointment according to the general principles of pharmacopoeia preparations, then mixed with the above-mentioned medicinal powder, and refined into honey to make pills, each weighing 6 grams.

本发明药物的功效是:补肾阳、填精补血、壮骨舒筋、活血化瘀。The effects of the medicine of the present invention are: tonifying kidney yang, replenishing essence and blood, strengthening bones and relaxing tendons, promoting blood circulation and removing blood stasis.

主治:肾阳虚型骨质疏松症。Indications: kidney yang deficiency type osteoporosis.

临床应用:骨质疏松、腰脊冷痛、屈伸不利、骨折未愈兼见畏寒肢冷、自汗、面色恍白、脉沉迟者,每次服一丸,每日三次,饭后黄酒100毫升送服,30天为一疗程。Clinical application: Osteoporosis, cold pain in the waist and spine, poor flexion and extension, unhealed fractures and chills in the limbs, spontaneous sweating, pale complexion, deep and slow pulse, take one pill each time, three times a day, rice wine 100 after meals Milliliter delivery service, 30 days as a course of treatment.

自1995年至1997年,应用本发明药物治疗骨质疏松症病人30例。30例病人骨X线平片显示:胸椎、髋骨均有不同程度骨密度降低。其中,6例腰椎压缩性骨折,4例股骨颈骨折,1例桡骨骨折,1例髋骨骨折。30例病人均有不同程度腰背疼痛病史、膝关节及髋部疼痛病史。From 1995 to 1997, 30 patients with osteoporosis were treated with the medicine of the present invention. The bone X-ray plain films of 30 patients showed that the bone density of the thoracic spine and hip bones decreased in varying degrees. Among them, there were 6 cases of lumbar compression fracture, 4 cases of femoral neck fracture, 1 case of radial fracture, and 1 case of hip fracture. All 30 patients had medical history of low back pain, knee joint and hip pain in different degrees.

对治疗结果的疗效评定标准是:The curative effect evaluation standard of treatment result is:

显效为用药后疼痛完全消失,活动功能显著增进;Significant effect refers to the complete disappearance of pain after medication, and significant improvement in activity function;

有效为用药后疼痛减轻,活动功能改善;It is effective for pain relief and improvement of activity function after medication;

无效为用药后疼痛未减轻,仍需服用其他药物。Ineffective means that the pain has not been alleviated after taking the medicine, and other medicines still need to be taken.

按上述疗效评价标准,治疗结果如下表:     疗效   例数   %     女          男   例数    %     例数     %     显效     13     43     10   33.3     3     10   有效     15     50     10   33.3     5    16.8   无效     2     7     1    3.3     1    3.3 According to the above curative effect evaluation criteria, the treatment results are as follows: curative effect Number of cases % female male Number of cases % Number of cases % markedly effective 13 43 10 33.3 3 10 efficient 15 50 10 33.3 5 16.8 invalid 2 7 1 3.3 1 3.3

本发明药物组合物治疗骨质疏松症总有效率93%。The total effective rate of the pharmaceutical composition of the present invention in treating osteoporosis is 93%.

实施例1Example 1

人参50克   羊骨50克    活鳝鱼100克当归50克50 grams of ginseng 50 grams of sheep bone 100 grams of live eel 50 grams of angelica

赤芍50克   川芎50克    熟地50克   接骨木100克50 grams of red peony, 50 grams of Chuanxiong, 50 grams of rehmannia, 100 grams of elderberry

自然铜100克蟹100克     牡蛎100克  大黄50克Natural Copper 100g Crab 100g Oyster 100g Rhubarb 50g

炙川乌50克 炙马钱子50克丹参50克   桃仁15克50 grams of Zhichuan black, 50 grams of roasted horse money, 50 grams of salvia miltiorrhiza, 15 grams of peach kernels

红花  15克Safflower 15g

按照处方量取人参、羊骨、活鳝鱼、蟹速冻干燥,为末,保持生物活性。将自然铜、牡蛎、大黄、炙川乌、炙马钱子研细末,余下诸药按药典制剂通则规定制成清膏,然后与上药粉混合,炼蜜为丸,制成100丸,每丸重6克。Take ginseng, sheep bone, live eel and crab according to the prescription and freeze-dry them quickly to keep biological activity. Grind natural copper, oyster, rhubarb, Zhichuanwu, and Zhinxuezi into fine powder, and the rest of the medicines are made into a clear ointment according to the general principles of pharmacopoeia preparations, then mixed with the above medicinal powder, refined into honey, and made into 100 pills. Pills weigh 6 grams.

实施例2Example 2

人参60克  羊骨30克    活鳝鱼80克当归70克60 grams of ginseng 30 grams of sheep bone 80 grams of live eel 70 grams of angelica

赤芍30克  川芎40克    熟地40克  接骨木80克Radix Paeoniae Rubra 30g Chuanxiong 40g Rehmannia Rehmanniae 40g Elderberry 80g

自然铜90克蟹90克      牡蛎90克  大黄40克Natural Copper 90g Crab 90g Oyster 90g Rhubarb 40g

炙川乌60克炙马钱子50克丹参40克  桃仁20克60 grams of Zhichuan black, 50 grams of roasted horse money, 40 grams of salvia miltiorrhiza, 20 grams of peach kernels

红花  25克Safflower 25g

按照处方量取人参、羊骨、活鳝鱼、蟹速冻干燥,为末,保持生物活性。将自然铜、牡蛎、大黄、炙川乌、炙马钱子研细末,余下诸药按药典制剂通则规定制成清膏,然后与上药粉混合,炼蜜为丸,制成100丸,每丸重6克。Take ginseng, sheep bone, live eel and crab according to the prescription and freeze-dry them quickly to keep biological activity. Grind natural copper, oyster, rhubarb, Zhichuanwu, and Zhinxuezi into fine powder, and the rest of the medicines are made into a clear ointment according to the general principles of pharmacopoeia preparations, then mixed with the above medicinal powder, refined into honey, and made into 100 pills. Pills weigh 6 grams.

实施例3Example 3

人参90克  羊骨60克    活鳝鱼100克当归40克Ginseng 90g Lamb bone 60g Live eel 100g Angelica 40g

赤芍50克  川芎50克    熟地80克   接骨木120克50 grams of red peony, 50 grams of Chuanxiong, 80 grams of rehmannia, 120 grams of elderberry

自然铜90克蟹100克     牡蛎100克  大黄30克Natural Copper 90g Crab 100g Oyster 100g Rhubarb 30g

炙川乌40克炙马钱子40克丹参80克   桃仁30克40 grams of Zhichuan black, 40 grams of roasted horse money, 80 grams of salvia miltiorrhiza, 30 grams of peach kernels

红花  20克Safflower 20g

按照处方量取人参、羊骨、活鳝鱼、蟹速冻干燥,为末,保持生物活性。将自然铜、牡蛎、大黄、炙川乌、炙马钱子研细末,余下诸药按药典制剂通则规定制成清膏,然后与上药粉混合,炼蜜为丸,制成100丸,每丸重6克。Take ginseng, sheep bone, live eel and crab according to the prescription and freeze-dry them quickly to keep biological activity. Grind natural copper, oyster, rhubarb, Zhichuanwu, and Zhinxuezi into fine powder, and the rest of the medicines are made into a clear ointment according to the general principles of pharmacopoeia preparations, then mixed with the above medicinal powder, refined into honey, and made into 100 pills. Pills weigh 6 grams.

Claims (4)

1、一种治疗骨质疏松症的药物组合物,其特征在于该组合物的组成按重量份为:1, a kind of pharmaceutical composition for the treatment of osteoporosis, it is characterized in that the composition of this composition is by weight: 人参      20-80份Ginseng 20-80 parts 羊骨      20-80份Lamb bone 20-80 parts 熟地      20-80份Rehmannia 20-80 parts 活鳝鱼    80-120份Live eel 80-120 servings 当归      30-80份Angelica 30-80 servings 赤芍      30-80份Paeoniae Rubra 30-80 parts 丹参      30-80份Danshen 30-80 parts 接骨木    80-120份Elderberry 80-120 servings 自然铜    80-120份Natural copper 80-120 parts 蟹        80-120份Crab 80-120 servings 大黄      30-80份Rhubarb 30-80 parts 炙马钱子  30-80份Roasted horse money 30-80 parts 桃仁      10-40份10-40 parts of peach kernel 红花      10-40份Safflower 10-40 parts 川芎      30-80份Chuanxiong 30-80 parts 炙川乌    30-80份Zhichuan black 30-80 servings 牡蛎      80-120份Oysters 80-120 servings 2、根据权利要求1上述的药物组合物,其特征在于所述的各组份的重量比为:2. The above-mentioned pharmaceutical composition according to claim 1, characterized in that the weight ratio of each component is: 人参      50份Ginseng 50 servings 羊骨      50份Lamb bones 50 parts 熟地      50份Rehmannia 50 servings 活鳝鱼    100份Live eel 100 servings 当归      50份Angelica 50 servings 赤芍      50份Radix Paeoniae Alba 50 parts 丹参      50份Danshen 50 parts 接骨木    100份elderberry 100 servings 自然铜    100份Natural copper 100 parts 蟹        100份Crab 100 servings 大黄       50份rhubarb 50 parts 炙马钱子   50份Roasted horse money 50 parts 桃仁       15份15 servings of peach kernels 红花       15份15 servings of safflower 川芎       50份Chuanxiong 50 parts 炙川乌     50份Zhichuan black 50 servings 牡蛎       100份Oysters 100 servings 3、一种药物制剂,其特征在于以权利要求1所述的药物组合物为原料组份。3. A pharmaceutical preparation, characterized in that the pharmaceutical composition as claimed in claim 1 is used as a raw material component. 4、根据权利要求3所述的药物制剂,其特征在于该制剂中还含有赋性剂。4. The pharmaceutical preparation according to claim 3, characterized in that the preparation also contains excipients.
CN97116975A 1997-10-06 1997-10-06 A kind of pharmaceutical composition for treating osteoporosis Expired - Fee Related CN1059115C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97116975A CN1059115C (en) 1997-10-06 1997-10-06 A kind of pharmaceutical composition for treating osteoporosis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97116975A CN1059115C (en) 1997-10-06 1997-10-06 A kind of pharmaceutical composition for treating osteoporosis

Publications (2)

Publication Number Publication Date
CN1179975A true CN1179975A (en) 1998-04-29
CN1059115C CN1059115C (en) 2000-12-06

Family

ID=5174249

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97116975A Expired - Fee Related CN1059115C (en) 1997-10-06 1997-10-06 A kind of pharmaceutical composition for treating osteoporosis

Country Status (1)

Country Link
CN (1) CN1059115C (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101181487B (en) * 2007-11-21 2010-06-23 朱强 Chinese medicine composition orally taken for curing osteosporosis

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101181487B (en) * 2007-11-21 2010-06-23 朱强 Chinese medicine composition orally taken for curing osteosporosis

Also Published As

Publication number Publication date
CN1059115C (en) 2000-12-06

Similar Documents

Publication Publication Date Title
CN1857541A (en) Plaster for treating rheumatism and osteoarthrosis
CN1129130A (en) Medicament for treatment of cervical spondylopathy
CN1502349A (en) Traditional Chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and strengtening lumbar
CN1124156C (en) Chinese-medicinal pills for treating rheumatism and preparing process thereof
CN1051471C (en) A kind of pharmaceutical composition for treating osteoporosis
CN1305513C (en) Broad-spectrum cancer-treating Chinese medicine prepn and its prepn process
CN101590166B (en) Traditional Chinese medicine combination for treating gout and preparation method thereof
CN1179975A (en) A kind of pharmaceutical composition for treating osteoporosis
CN1259065C (en) A kind of traditional Chinese medicine preparation for fast bone setting
CN1054541C (en) Traditional Chinese medicine for treating mastosis
CN1140071A (en) Anticancer drug and preparing method thereof
CN1256976C (en) Anti-cancer Chinese medicinal composition and its preparing method
CN1127968C (en) Oral powder medicine Xiaobaisan for treating leukotrichia and its preparation method
CN1191751A (en) Chinese medicine Gutongning and its preparation
CN1411861A (en) Medicine for curing acute injury of muscle and tendon and its preparation method
CN1150016C (en) Medicine for treating fever caused by lupus erythematosus and other immunological disease
CN100349592C (en) Chinese medicine composition for treating bone disease, its preparation and use thereof
CN100339095C (en) Cervical spondylosis treating Chinese medicine composition
CN1304043C (en) Longhedan pills and their preparation
CN1167450C (en) Medicine for treating hyperosteogeny and bone retromorphosis and its preparing process
CN1050056C (en) Medicine for treating osteoproliferation
CN1319559C (en) Pharmaceutical composition for treating muscle and bone pain and preparation method thereof
CN1150015C (en) Medicine for treating leucocytopenia caused by lupus erythematosus
CN1435217A (en) Bone-strengthening medicine and producing method thereof
CN119607090A (en) A Chinese medicine combination oral medicine for osteoporosis and its preparation method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee